Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03138499
Brief Title: A Study of Nivolumab Plus Brentuximab Vedotin Versus Brentuximab Vedotin Alone in Patients With Advanced Stage Classical Hodgkin Lymphoma, Who Are Relapsed/ Refractory or Who Are Not Eligible for Autologous Stem Cell Transplant, (CheckMate 812)

First Submitted : May 1, 2017
First Submitted that Met QC Criteria : May 1, 2017
First Posted : May 3, 2017

Last Update Submitted that Met QC Criteria : October 25, 2019
Last Update Posted : October 28, 2019